MétaCan
Menu
Back to cohort

Genome-wide association study of cisplatin-induced peripheral neuropathy (CIPN) in testicular cancer survivors.

2016· article· en· W2734681090 on OpenAlexaff
Omar El Charif, Heather E. Wheeler, Taisei Mushiroda, Michiaki Kubo, Eric R. Gamazon, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Clair J. Beard, Chunkit Fung, Costantine Albany, Eileen Johnson, Sophie D. Fosså, Nancy J. Cox, Lawrence H. Einhorn, Lois B. Travis, M. Eileen Dolan

Bibliographic record

VenueJournal of Clinical Oncology · 2016
Typearticle
Languageen
FieldMedicine
TopicCancer Treatment and Pharmacology
Canadian institutionsPrincess Margaret Cancer CentreUniversity Health Network
Fundersnot available
KeywordsMedicineChemotherapy-induced peripheral neuropathyPeripheral neuropathyInternal medicineGenome-wide association studyImputation (statistics)Single-nucleotide polymorphismCumulative doseOncologySensory neuropathyCancerCisplatinChemotherapyGenotypeGeneGeneticsEndocrinologyDiabetes mellitus

Abstract

fetched live from OpenAlex

4543 Background: CIPN is a potentially permanent side effect of cisplatin chemotherapy. CIPN remains a major clinical challenge due to lack of effective treatment, impact on quality of life and unexplained inter-individual variability. Methods: Testicular cancer patients (n = 847) given cisplatin-based therapy (median dose: 400 mg/m2) were assessed for responses to the validated EORTC QLQ-CIPN20 questionnaire. Associations were evaluated between frequency of sensory neuropathy and cumulative cisplatin dose, smoking history and age. Using the Illumina HumanOmniExpressExome chip and with imputation, 5.1 million SNPs passed quality control (QC) for GWAS inclusion. A gene-based method, PrediXcan, was used to consider associations between the genetically determined component of gene expression and CIPN. Results: Sensory neuropathy was common (57% having any symptom). CIPN sensory items (n = 8) indicated excellent internal consistency (alpha coefficient = 0.88). Using each patient’s mean sensory neuropathy score, we sorted them into 3 ordinal groups according to severity: 43% none, 41% a little, 16% quite a bit/very much. Only age and smoking status, not dose, were significantly related to sensory neuropathy (OR = 1.04 [95% CI 1.03-1.06] and 1.5 [95% CI 1.2-2.0], respectively). The top 2 SNPs (P = 5 x 10-7) from a GWAS of 677 patients that passed QC, were each associated with greater risk of sensory neuropathy (OR = 1.9 [95% CI 1.5-2.4] and 1.9 [95% CI 1.5-2.5]). These SNPs are expression QTLs for LYPD3 (rs12797447), SNX8 and GSTT1 (rs4757366) in lymphoblastoid cell lines. PrediXcan identified lower predicted expression of RPRD1B in whole blood (5453 genes tested) met genome-wide significance for association with increased sensory neuropathy risk (P = 3 x 10-6). Conclusions: Our traditional GWAS identified several SNPs associated with CIPN that were functionally important due to their association with gene expression. Our gene-based test implicated RPRD1B, known to play a role in cell cycle regulation, as associated with CIPN. Future studies will focus on functional validation, analysis of a replication set and meta-analysis with other CIPN studies to identify drug-independent variants.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.008
Threshold uncertainty score0.016

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.002
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.128
GPT teacher head0.479
Teacher spread0.351 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicCancer Treatment and PharmacologyFrench-language works237,207